Jonathan Schwartz

Jonathan Schwartz is the Chief Medical Officer at Rocket Pharmaceuticals, a company focused on developing gene-modified cell therapies for rare diseases. Prior to this, Jonathan held positions at Stemline Therapeutics and ImClone Systems, where Jonathan led clinical development and FDA approval processes for various therapies. With a background in medicine and a focus on oncology, Jonathan's career has been dedicated to advancing treatments for complex diseases.